The Effects of Two Different Breathing Techniques and Forward-Leaning Position on Physiological Parameters
Determination of the Effects of Two Different Breathing Techniques and Forward-Leaning Position on Physiological Parameters in Patients With Chronic Obstructive Pulmonary Disease
1 other identifier
interventional
96
1 country
1
Brief Summary
This study aims to determine the effects of balloon inflation and pursed-lip breathing exercises, in addition to the forward-leaning position, on physiological parameters in individuals with Chronic Obstructive Pulmonary Disease (COPD). The hypotheses of the study are as follows: H1\_1: The forward-leaning position and balloon inflation breathing exercise have a positive effect on physiological parameters in patients with Chronic Obstructive Pulmonary Disease (COPD). H1\_2: The forward-leaning position and pursed-lip breathing exercise have a positive effect on physiological parameters in patients with COPD. H1\_3: There is a significant difference in physiological parameters between the balloon inflation and pursed-lip breathing exercise groups and the control group. Within this scope, the study will be conducted with three groups: Intervention Group 1: Balloon inflation exercise applied in addition to the forward-leaning position. Intervention Group 2: Pursed-lip breathing exercise applied in addition to the forward-leaning position. Control Group: Standard practice implemented in the institution where the study is conducted. Participants:
- A home exercise program will be designed for both intervention groups, allowing them to perform the exercises independently each day.
- The exercises will start with three sessions per day and will be increased by one session each week, continuing for a total of four weeks.
- Participants will visit the outpatient clinic in the 4th week for assessments and tests.
- Patients will be contacted weekly by the researcher via phone to ensure adherence to the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2025
CompletedFirst Submitted
Initial submission to the registry
March 28, 2025
CompletedFirst Posted
Study publicly available on registry
April 15, 2025
CompletedApril 15, 2025
March 1, 2025
1 year
March 28, 2025
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
blood pressure
4 weeks later
pulse
4 weeks later
respiratory rate
4 weeks later
saturation
4 weeks later
Secondary Outcomes (6)
Forced Vital Capacity (FVC)
4 weeks later
Forced Expiratory Volume in One Second (FEV1)
4 weeks later
FEV1/FVC ratio
4 weeks later
Peak Expiratory Flow (PEF)
4 weeks later
Modified Borg Dyspnea Scale (MBS)
4 weeks later
- +1 more secondary outcomes
Study Arms (3)
Pursed-lip breathing exercise
EXPERIMENTALBalloon inflation exercise
EXPERIMENTALStandard treatment
EXPERIMENTALInterventions
Balloon inflation exercise was applied in addition to the forward-leaning position.
The pursed-lip breathing exercise was applied in addition to the forward-leaning position.
Standard practice is implemented in the institution where the study is conducted.
Eligibility Criteria
You may qualify if:
- Patients who have no communication and cooperation problems,
- Can speak and understand Turkish,
- Have a baseline saturation of \>90%,
- Have been diagnosed with Stage II and Stage III COPD,
- Have not had any infection or COPD exacerbation for at least 3 months,
- Have not participated in a pulmonary rehabilitation program in the last 3 months,
- Can walk without assistance,
- Do not have serious and/or unstable heart disease, neuromuscular disease, orthopedic disease or mental illness that may impair their physical activities of daily living,
- Willing to participate in the study will be included.
You may not qualify if:
- Patients who have been hospitalized since the start of the study,
- Those receiving continuous oxygen therapy,
- Those who have cooperation problems,
- Those who cannot adapt to exercise,
- Those who have 2-3 or more acute attacks per year,
- Those with a history of pulmonary hypertension, malignancy, pulmonary thromboembolism, obstructive sleep apnea, unstable angina or myocardial infarction,
- Patients with a pulse rate over 120/minute will be excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences Turkey
Istanbul, Üsküdar, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Semra Aciksoz, RN, Assistant Professor, PhD
University of Health Sciences Turkey, Hamidiye Faculty ofNursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 28, 2025
First Posted
April 15, 2025
Study Start
January 3, 2024
Primary Completion
January 4, 2025
Study Completion
February 2, 2025
Last Updated
April 15, 2025
Record last verified: 2025-03